Heart Attack
Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
Published in Blood Weekly, November 22nd, 2007
Data to be presented at the 71st annual meeting of the American College of Rheumatology (ACR) showed that when over- the-counter (OTC) naproxen sodium, commercially sold as Aleve(R), was added to an aspirin therapy regimen, there was no change in platelet aggregation measures versus baseline. Unlike ibuprofen, which can negate the intended cardiovascular benefit of aspirin therapy, an OTC dose of naproxen sodium did not change the antiplatelet effect profile seen with aspirin therapy alone.
The aggregation or accumulation of platelets can cause clotting in the arteries, which can lead to a heart attack or ischemic stroke. It has been reported that one in five Americans...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-11-22)
More Articles from Blood Weekly
- Sepsis
In the laboratory, green tea proves a powerful medicine against severe sepsis - Acute Promyelocytic Leukemia
Researchers from National University publish new studies and findings in the area of acute promyelocytic leukemia - Blood Components
Research from J. Cid and colleagues provide new insights into blood components - Chagas Disease
AcroMetrix Announces Launch of PeliSpy Chagas Positive Control - Dengue Fever
New findings in dengue fever described from University of Malaya, Medical Department - Gaucher Disease
New Gaucher disease study findings recently were published by researchers at Medical University of Vienna - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
